These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 39106314)

  • 1. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.
    Nguyen AT; Curtis KM; Tepper NK; Kortsmit K; Brittain AW; Snyder EM; Cohen MA; Zapata LB; Whiteman MK;
    MMWR Recomm Rep; 2024 Aug; 73(4):1-126. PubMed ID: 39106314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U.S. Selected Practice Recommendations for Contraceptive Use, 2024.
    Curtis KM; Nguyen AT; Tepper NK; Zapata LB; Snyder EM; Hatfield-Timajchy K; Kortsmit K; Cohen MA; Whiteman MK;
    MMWR Recomm Rep; 2024 Aug; 73(3):1-77. PubMed ID: 39106301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.
    Curtis KM; Tepper NK; Jatlaoui TC; Berry-Bibee E; Horton LG; Zapata LB; Simmons KB; Pagano HP; Jamieson DJ; Whiteman MK
    MMWR Recomm Rep; 2016 Jul; 65(3):1-103. PubMed ID: 27467196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U.S. Selected Practice Recommendations for Contraceptive Use, 2016.
    Curtis KM; Jatlaoui TC; Tepper NK; Zapata LB; Horton LG; Jamieson DJ; Whiteman MK
    MMWR Recomm Rep; 2016 Jul; 65(4):1-66. PubMed ID: 27467319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. U S. Medical Eligibility Criteria for Contraceptive Use, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2010 Jun; 59(RR-4):1-86. PubMed ID: 20559203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recommendations for the Use of Contraception Among Women at High Risk for HIV Infection.
    Tepper NK; Curtis KM; Cox S; Whiteman MK
    MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(14):405-410. PubMed ID: 32271729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition.
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2013 Jun; 62(RR-05):1-60. PubMed ID: 23784109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.
    Tepper NK; Krashin JW; Curtis KM; Cox S; Whiteman MK
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):990-994. PubMed ID: 28934178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removing Unnecessary Medical Barriers to Contraception: Celebrating a Decade of the U.S. Medical Eligibility Criteria for Contraceptive Use.
    Curtis KM; Zapata LB; Pagano HP; Nguyen A; Reeves J; Whiteman MK
    J Womens Health (Larchmt); 2021 Mar; 30(3):293-300. PubMed ID: 33370207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(24):449-52. PubMed ID: 22717514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive Planning: Short-Acting Reversible Contraceptives.
    Wilson ML; Godfrey EM; Glass S; Zhang Y
    FP Essent; 2024 Mar; 538():13-24. PubMed ID: 38498325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. United States medical eligibility criteria for contraceptive use 2010: a review of changes.
    Jacobson JC; Aikins Murphy P
    J Midwifery Womens Health; 2011; 56(6):598-607. PubMed ID: 22060220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2016 Updates to US Medical Eligibility Criteria for Contraceptive Use and Selected Practice Recommendations for Contraceptive Use: Highlights for Adolescent Patients.
    Hoopes AJ; Simmons KB; Godfrey EM; Sucato GS
    J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):149-155. PubMed ID: 28167141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.
    Lauring JR; Lehman EB; Deimling TA; Legro RS; Chuang CH
    Am J Obstet Gynecol; 2016 Sep; 215(3):330.e1-7. PubMed ID: 27059507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States.
    Curtis KM; Jamieson DJ; Peterson HB; Marchbanks PA
    Contraception; 2010 Jul; 82(1):3-9. PubMed ID: 20682138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Committee opinion no. 505: understanding and using the U.S. Medical Eligibility Criteria For Contraceptive Use, 2010.
    Obstet Gynecol; 2011 Sep; 118(3):754-760. PubMed ID: 21860318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):878-83. PubMed ID: 21734635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.